Related Experiment Video

Updated: Mar 13, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis

Jeniece Trast Ilkowitz1, Steven Choi, Michael L Rinke

  • 1The Children's Hospital at Montefiore, Bronx, New York (Mss Ilkowitz and Vandervoot, and Drs Choi, Rinke, and Heptulla); and Albert Einstein College of Medicine, Bronx, New York (Drs Choi, Rinke, and Heptulla).

Quality Management in Health Care
|October 18, 2016
PubMed

Insights

A comprehensive management plan significantly reduced diabetes ketoacidosis (DKA) hospitalizations and readmissions in children with type 1 diabetes mellitus (T1DM). This approach also shortened the length of stay for DKA patients.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Healthcare Management

Background:

  • Diabetes ketoacidosis (DKA) is a severe complication of type 1 diabetes mellitus (T1DM).
  • Reducing DKA admissions in pediatric T1DM requires a coordinated and comprehensive management strategy.
  • Key metrics for DKA management include admission rates, 30-day readmissions, and length of stay (LOS).

Purpose of the Study:

  • To decrease DKA admissions in children with T1DM.
  • To reduce 30-day readmissions for DKA.
  • To shorten the length of stay (LOS) for DKA admissions.

Main Methods:

  • A multipronged intervention was implemented in 2011, including increased insulin pump use, enhanced diabetes education, improved provider access, and patient/family support.
  • A before-and-after study design compared outcomes from 2007-2010 (preintervention) to 2012-2014 (postintervention).
  • Administrative data were analyzed using Wilcoxon rank sum and Fischer exact tests.

Main Results:

  • DKA admissions decreased by 44% postintervention (16.7 to 9.3 per 100 patient-years; P = .006).
  • Unique patient 30-day readmissions dropped from 20% to 5% (P = .001).
  • Median LOS significantly decreased postintervention (P < .0001), and hemoglobin A1C improved in a subset of patients.

Conclusions:

  • Clinical and program interventions significantly reduced DKA hospitalizations, 30-day readmissions, and LOS in pediatric T1DM.
  • Continuous quality improvement is essential for optimizing DKA outcomes.
  • The study highlights the effectiveness of a multifaceted approach to managing T1DM complications.
Abstract

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.4K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K